Medical engineering is one of the most important industries in Germany and Europe, after the automotive industry and mechanical and plant engineering. With a market volume of over 160 billion euros in Europe, it not only makes a significant contribution to the health of our economies but also provides almost 900,000 jobs across Europe. There are not only numerous world-class corporations in Europe but also many small and medium-sized companies, which are characterized by their innovative capability and strong growth. They have, however, been a little slow off the mark when it comes to digitalizing their business processes. But that is now changing.
Regardless of its economic health, the medical engineering industry is subject to a high level of competitive pressure: rising costs, increasing international competition and ever shorter innovation cycles are forcing companies to examine their development and production processes and make them more efficient.
A major factor in increasing efficiency is reducing the enormous amount of manual effort required to ensure compliance and traceability throughout all phases of the product lifecycle. The key to achieving this is the use of powerful PLM/ALM solutions.
In addition to risk management, traceability is the most important driver for PLM/ALM projects in the medical engineering industry. This is not least due to the fact that hardly any other industry has to comply with such strict regulatory requirements if they want to be able to launch their products onto the market. The main legal framework for all medical products is the EU Medical Device Regulation (MDR), which specifies the requirements for classifying products according to risk classes. The MDR requires traceability, including unique product identification throughout the entire product lifecycle, and specifies how it is to be documented. It also requires that medical equipment manufacturers monitor the performance and safety of their products even after they have been launched onto the market.